Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuhiro Kakimi

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Human Cell|May 19, 2004
Immune-based novel therapies for chronic hepatitis C virus infectionKazuhiro Kakimi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 17, 2022
[Understanding Tumor Immunity by Immune Genome Profiling of the Cancer Tissue]Kazuhiro Kakimi
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
γδ T cell-based cancer immunotherapyHirokazu Matsushita, Kazuhiro Kakimi
Breast Cancer (Tokyo, Japan)|May 6, 2025
Why combine and why neoadjuvant? Tumor immunological perspectives on chemoimmunotherapy in triple-negative breast cancerKazuhiro Kakimi, Tomoharu Sugie
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2016
[Neoantigens and Whole-Exome Sequencing]Takahiro Karasaki, Jun Nakajima, Kazuhiro Kakimi
Lung Cancer (Amsterdam, Netherlands)|December 9, 2008
Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancerKazuhiro Kakimi, Jun Nakajima, Hiromi Wada
Cells|November 26, 2025
NeoPAIR-T: Functional Mapping of Neoantigen-TCR Pairs Using a CRISPR-Engineered Jurkat Reporter SystemKoji Nagaoka, Yukari Kobayashi, Kazuhiro Kakimi
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Dendritic cells for cancer immunotherapy]Kazuhiro Kakimi, Atsushi Kondo, Hirokazu Matsushita
International Immunology|December 13, 2006
Maintenance of memory CD8+ T cell diversity and proliferative potential by a primary response upon re-challengeMakoto Kurachi, Kazuhiro Kakimi, Satoshi Ueha, et al.
Surgery Today|May 3, 2011
γδ T-cell immunotherapy for lung cancerYukihiro Yoshida, Jun Nakajima, Hiromi Wada, et al.
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Human Cell|May 19, 2004
Immune-based novel therapies for chronic hepatitis C virus infectionKazuhiro Kakimi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 17, 2022
[Understanding Tumor Immunity by Immune Genome Profiling of the Cancer Tissue]Kazuhiro Kakimi
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
γδ T cell-based cancer immunotherapyHirokazu Matsushita, Kazuhiro Kakimi
Breast Cancer (Tokyo, Japan)|May 6, 2025
Why combine and why neoadjuvant? Tumor immunological perspectives on chemoimmunotherapy in triple-negative breast cancerKazuhiro Kakimi, Tomoharu Sugie
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2016
[Neoantigens and Whole-Exome Sequencing]Takahiro Karasaki, Jun Nakajima, Kazuhiro Kakimi
Lung Cancer (Amsterdam, Netherlands)|December 9, 2008
Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancerKazuhiro Kakimi, Jun Nakajima, Hiromi Wada
Cells|November 26, 2025
NeoPAIR-T: Functional Mapping of Neoantigen-TCR Pairs Using a CRISPR-Engineered Jurkat Reporter SystemKoji Nagaoka, Yukari Kobayashi, Kazuhiro Kakimi
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Dendritic cells for cancer immunotherapy]Kazuhiro Kakimi, Atsushi Kondo, Hirokazu Matsushita
International Immunology|December 13, 2006
Maintenance of memory CD8+ T cell diversity and proliferative potential by a primary response upon re-challengeMakoto Kurachi, Kazuhiro Kakimi, Satoshi Ueha, et al.
Surgery Today|May 3, 2011
γδ T-cell immunotherapy for lung cancerYukihiro Yoshida, Jun Nakajima, Hiromi Wada, et al.
Pageof 16